The purpose of this post-market clinical follow up study is to assess the safety and performance of Aesthetic Group cannulas. The study will evaluate the outcome of the Aesthetic Group cannulas range over a period of 1 month after intervention.

Inclusion Criteria:

• Patient age ≥ 18 years at intervention
• Patient who will undergo a lipofilling treatment with at least one cannula of Aesthetic Group
• Patient informed of his/her participation and willing to participate in the study.
• Patient able to read, write and understand French.

Exclusion Criteria:

• Patient deprived of freedom, under guardianship/curatorship or placed under judicial protection
• Patient unable to follow study procedures
• Patient with hematologic abnormalities, prior radiotherapy or chemotherapy
• Chronic use of medicines or drugs
• Patient with diabetes mellitus
• Patient with connective tissue diseases, any type of fat tissue disorder (lipodystrophy)
• Patient with bleeding disorders; immune deficits; heart, liver, and kidney insufficiency
• Patient with allergies to local anaesthetics
• Patient with pacemaker and serious heart rhythm disorders
• Pregnant and breastfeeding women

The study population is directly linked to target population for autograft with Aesthetic group's cannulas